Sysmex America, a global provider of medical diagnostic testing equipment and information systems technology and CellaVision have extended and broadened working relationship via the completion of a recent global distribution agreement.
The agreement gives Sysmex a non-exclusive right to sell CellaVision’s products in hematology laboratories worldwide. As of April 1, 2010, the non-exclusive agreement comprises all international markets except Canada.
Sysmex has added the CellaVision DM1200 cell image analysis analyzer to the Sysmex hematology product offering. The DM1200 enables Sysmex to meet the growing demand for automated cell image analysis, which is said to improve both the quality of results and the productivity of laboratories performing mid-volume testing.
The CellaVision DM1200 opens up new ways of handling manual differentials traditionally performed on a microscope by automatically performing a preliminary differential count on peripheral blood.
The analyzer pre-classifies the white blood cells, pre-characterizes parts of the red morphology and provides functionality for platelet estimation.
John Kershaw, president and CEO of Sysmex America, said: “The CellaVision DM1200, which locates, identifies, and pre-classifies blood cells by means of automatic microscopy and advanced image processing, greatly enhances Sysmex America’s hematology product offering. We trust this addition to our hematology portfolio will serve our customers well as they continue to navigate through a challenging health care environment.”